Vivos Therapeutics Quote - VVOS

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.13

Bid

3.12

Offer

3.25

Volume

270,382

3.0299 Day's Range 3.28

1.91 52 Week Range 48.79

Market Cap

10.647M

Previous Close

2.95

Open

3.0299

Last Trade

3.14

Last Trade Time

Financial Volume

US$ 858,296

VWAP

3.1744

Average Volume (3m)

1,450,532

Shares Outstanding

3,401,488

Dividend Yield

PE Ratio

-0.80

Earnings Per Share (EPS)

-3.99

Revenue

13.8M

Net Profit

-13.58M

Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral applian... Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

vivos.com

Headquarters

Wilmington, Delaware, USA

Founded

Vivos Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker VVOS. The last closing price for Vivos Therapeutics was US$2.95. Over the last year, Vivos Therapeutics shares have traded in a share price range of US$ 1.91 to US$ 48.79.

Vivos Therapeutics currently has 3,401,488 shares in issue. The market capitalisation of Vivos Therapeutics is US$10.03 million. Vivos Therapeutics has a price to earnings ratio (PE ratio) of -0.80.

Form 8-K - Current report

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update

Revenue Increased 17% Quarter over Quarter Operating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ET LITTLETON, Colo., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Vivos...

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

LITTLETON, Colo., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and...

Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

LITTLETON, Colo., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.02	-0.634920634921	3.15	3.28	2.51	134669	2.82968958	CS
4	0.43	15.9259259259	2.7	3.48	2.51	161858	2.94672165	CS
12	0.3	10.6007067138	2.83	5.95	2.225	1450532	3.94699821	CS
26	0.93	42.2727272727	2.2	5.95	1.91	700266	3.88015252	CS
52	-1.86	-37.2745490982	4.99	48.79	1.91	666461	15.5766998	CS
156	-66.37	-95.4964028777	69.5	92.25	1.91	1194681	23.42088923	CS
260	-173.62	-98.2291371994	176.75	360.25	1.91	1175900	52.59801412	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDYNPalladyne AI Corporation	US$ 4.59 (129.50%)	83.07M
QMCOQuantum Corporation	US$ 9.11 (126.62%)	39.48M
NANano Labs Ltd	US$ 8.26 (89.02%)	2.03M
XCURExicure Inc	US$ 18.60 (71.27%)	4.59M
SKKSKK Holdings Limited	US$ 1.75 (59.09%)	107.47M
AMIXAutonomix Medical Inc	US$ 6.21 (-54.07%)	946.09k
CETXCemtrex Inc	US$ 0.1146 (-41.74%)	24.39M
MSWMing Shing Group Holdings Ltd	5.90 (-35.52%)	417.08k
RMSGReal Messenger Corporation	US$ 3.09 (-26.25%)	313.51k
ENSCEnsysce Biosciences Inc	US$ 0.4414 (-25.49%)	4M
ELABElevai Labs Inc	US$ 0.0201 (-0.50%)	415.87M
NVDANVIDIA Corporation	US$ 141.95 (-3.22%)	229.93M
SMCISuper Micro Computer Inc	US$ 33.15 (11.62%)	155.43M
VRPXVirpax Pharmaceuticals Inc	US$ 0.5501 (-6.72%)	154.17M
SOUNSoundHound AI Inc	US$ 8.24 (18.05%)	103.6M